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Background: Remote cardiac rhythm monitoring and diagnosis has been well incorporated in the tele-
health service model. The prevalence and incidence of abnormal ventricular beats, based on utilizing a
symptom-driven portable remote electrocardiography (ECG) device, remains less well explored.
Methods: We studied 339 consecutive study participants, which included 192 individuals from outpa-
tient clinics who were enrolled via a symptom-driven protocol; 147 participated in a heart rhythm
screening program. All participants underwent 24-hour data transfer using a handheld portable elec-
trocardiogram (ECG) device (DailyCare Biomedical Inc., Taoyuan City, Taiwan) with automatic ECG
wavelet data extraction software (InstantCheck, version 4.0; DailyCare Biomedical Inc., Taoyuan City,
Taiwan).
Results: Among 1152 data transferred (98.4% success rate), we noticed 32.5% of the study participants
had evidence of cardiac arrhythmias with permanent or paroxysmal atrial ﬁbrillation (AF) constituting
50.9% of arrhythmias. Individuals with a history of heart failure (odds ratio [OR], 3.37; 95% conﬁdence
interval [CI], 1.69e6.74), diabetes (OR, 3.03; 95% CI, 1.67e5.49), and cardiovascular disease (OR, 3.71; 95%
CI, 2.05e6.7) had a higher AF risk. Both populations had an age-related increase in AF, even in multi-
variate models (OR, 1.72; 95% CI, 1.31e2.24 per þdecade).
Conclusion: The handheld ECG device shows clinical feasibility with high rate for AF detection with a
similar trend toward a higher prevalence with aging from different settings. These data suggested that
portable ECG device via remote care system may aid in clinical diagnosis, therapeutic interventions, or
patient referral for cardiac arrhythmias.
Copyright © 2015, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
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tric Emergency & Critical Care Me1. Introduction
The standard 12-lead electrocardiogram (ECG) has been used
clinically for more than 10 decades for the diagnosis of myocardial
ischemia or cardiac arrhythmias1. Conventional 12-lead ECG on the
body surface may provide useful information with more detailed
electrical activity, although simpliﬁed bipolar connections of limb
leads can be easily reproduced, based on Einthoven's triangle2. A
bipolar device can also theoretically create multiple combinations
in clinical use, which include augmented limb leads, which are
useful and feasible3.dicine. Published by Elsevier Taiwan LLC. All rights reserved.
Handheld Remote Electrocardiography Recording Device 207In the recent era, increasingly more elderly populations in
developed countries are experiencing one or more cardiovascular
disease4. Current ambulatory ECG monitoring systems must be
performed on site with a 12-lead patch and take considerable time
and effort for subsequent diagnostic interpretation1. A portable ECG
recorder with rapid data transmission and real time assessment to
report sporadic or chronic cardiac events (e.g., tachyarrhythmias
featured by a rapid and irregular cardiac cycle length) may be
clinically feasible5e7, whereas efforts to broaden its clinical use and
value via a standardized protocol may be worthwhile. To meet the
requirement and demand for potential rapidly growing populations
and a large amount of data transfer for clinical interpretation, a
remote monitoring or wireless data transmission of rate and
rhythm proﬁles to the specialist based on more advanced tech-
nology may allow early intervention that can prevent clinical
events8.
Atrial ﬁbrillation (AF), an emerging cardiac arrhythmia in an
elderly society, has recently been a primary target for the use of
such device implementation, with the aim of preventive stroke
treatment and heart rate control because of its association with
worse clinical outcomes and stroke9e12. In our current work, we
examined the data by using a handheld palm-sized ECG device for
clinical use, and explored data precision and its clinical correlation
and efﬁcacy in our pilot study.
2. Materials and methods
From June 2012 to December 2014, we consecutively enrolled
study participants from outpatient clinics who underwent popu-
lation screening programs via our remote care center in a tertiary
medical center in Northern Taiwan. In total, 339 consecutive par-
ticipants were collected. Study participants without baseline de-
mographics were excluded (n ¼ 42). We examined several ECG
parameters using a handheld ECG device, and further analyzed its
feasibility, frequency of use, and clinical associations among the
study participants.
2.1. Study protocols and study participant enrollment
We adopted two clinical protocols in this study: (1) the long-
duration protocol, which is a symptom-driven clinical protocol
implemented in accordance with the institution outpatient visits
(n ¼ 192) and (2) the short-duration protocol, which is rhythm
screening for a generally elderly population (n ¼ 147, 75%, >65
years old)], which supposedly has a higher risk of cardiac ar-
rhythmias prevalence (e.g., AF in a community-dwelling popula-
tion, or for screening purposes in an elderly population). For the
long-duration symptom-driven clinical protocol, we conﬁrmed a
negative 24-hour Holter or multiple body surface 12-lead ECG
study before using the handheld ECG device. This protocol aimed to
test the feasibility of using the handheld ECG device for certain
symptom-driven cardiac arrhythmias on a monthly basis. For the
screening program, we enrolled individuals who were willing to
have their baseline heart rhythm recorded and studied (for
continuous 30 seconds) during each public educative activity for
the device from June 2012 to December 2014. The aim was to
identify the prevalence of AF and other cardiac arrhythmias in a
cross-sectional survey. This study was approved by the institutional
review board committee, Taipei, Taiwan (approval number
15MMHIS018) for data analysis and conduction.
2.2. Electrocardiography data acquisition and recording
A portable, handheld ECG device that had a large liquid crystal
display panel with validated signal processing was used uniformlyin this study design and may render convenient data recording and
transportation (Figure 1). The body R-wave related to the ventric-
ular depolarization and mechanical contraction was deﬁned by the
most signiﬁcant deﬂectionwavelet and feature extraction from ECG
recordings. Routine reports for users and patients will be made for
each single data transfer, and will primarily focus on abnormal
ﬁndings, if any. Software-based automatic quantiﬁcation of several
output ECGwavelet parameters such as heart rate (HR), PR interval,
QRS duration, ST segment, QT, and corrected QT interval were all
displayed by the software by DailyCare Biomedical Inc.
(InstantCheck, ReadMyHeart Handheld ECG Recorder V2.0;
Taoyuan City, Taiwan; Figure 2). Participants were referred back to
clinics for a complete survey and next stage management if they
had a suspected arrhythmia underlying the ECG data such as AF,
ﬂutter, widened QRS complex, premature atrial contractions, pre-
mature ventricular contractions, paroxysmal supraventricular
tachycardia or atrioventricular block that may necessitate phar-
macological or medical interventions. The nursing assistant in
charge of the patient had monthly phone-based clinical follow up,
based on the patient's clinical conditions or symptoms, medication
use, and schedule for next visit.
2.3. Statistical analysis
In our study, continuous data were expressed as the mean and
standard deviation and categorical information was expressed as
the frequency and proportion of prevalence. These two sets of data
were then compared by the Chi-square test or Fisher's exact test, as
appropriate. Baseline continuous data were compared by the Stu-
dent t test between groups. Trend analysis was used for continuous
data across ordered categories (e.g., age groups). Univariate and
multivariate models were conducted to examine the role of age in
predicting AF identiﬁcation, and baseline clinical covariates such as
sex distribution, medical history, and frequency of data transfer
were considered confounding factors.
All data were analyzed using a commercial software STATA 9
package (Stata Corporation, College Station, TX, USA). The signiﬁ-
cance of p level (a-value) for all analysis was two-sided, and a value
of less than 0.05 was considered statistically signiﬁcant.
3. Results
3.1. Baseline demographics
Table 1 displays the baseline demographics of the study par-
ticipants collectively and in the different study protocols. Our table
shows that, among all symptom-driven study participants (n¼ 192;
mean age, 70.6 ± 18.3 years; 42% female), individuals tended to be
younger and tended to have a lower prevalence of diabetes and
cardiovascular diseases, compared to the screening population
(n ¼ 147; mean age, 75.8 ± 17.2; 55.8% female). The overall mean
age of all study participants was 72.9 ± 18 years (n ¼ 339, 48.1%
female), and 44% of participants had hypertension; 26.3% had dia-
betes, 13.6% had heart failure, and 33% had cardiovascular diseases.
The age-stratiﬁed differences in service months, total times of data
transfer and prevalence of AF or associated cardiac arrhythmias
based on study protocols were further displayed (Tables 2 and 3).
3.2. Evaluation of the clinical efﬁcacy and outcomes
Among all study participants, we observed that 110 (32.5%)
study participants had evidence of cardiac arrhythmias of all types
and 50.9% of the arrhythmias were AF. Participants with a known
medical history of heart failure (OR, 3.37; 95% CI, 1.69e6.74;
p ¼ 0.001), diabetes (OR, 3.03; 95% CI, 1.67 e5.49), and
Figure 1. The product view of the electrocardiogram (ECG) device (DailyCare Biomedical Inc, Taoyuan City, Taiwan). The product includes a panel and electrodes for the thumb press
(red circles) and the power system (A) with USB and the external electrode sockets displayed (B). The monitor displays the ECG signaling and fundamental information during data
acquisition and recording (C). LCD ¼ liquid crystal display; USB ¼ universal serial bus.
Figure 2. The software interface of InstantCheck window (ver 4.0 ECG analysis; DailyCare Biomedical Inc., Taoyuan, Taiwan), which is built on a distal institution site for automatic
electrocardiogram (ECG) wavelets analysis (i.e., ECG diagram display), which may allow all ECG parameters (red frame at right lower panel). The assessment of P wave morphology
and RR regularity (blue dotted spots on each QRS pattern) can be achieved by program analysis.
W.-L. Chang et al.208cardiovascular disease (OR, 3.71; 95% CI, 2.05e6.7; both p < 0.001)
had a higher AF risk. Both populations showed age-related increase
in AF, even in multivariate models (OR, 1.72; 95% CI, 1.31e2.24
per þdecade). Age-related AF identiﬁcation by using a handheld
ECG device is further displayed in Table 4. Advanced age wasassociated with a high incidence of AF in participants of both study
protocols (OR, 1.42 and 2.59; 95% CI, 1.09e1.86 and 1.54e4.35 for
the symptom-driven and screening protocols, respectively; for
both, p < 0.05), whereas other types of cardiac arrhythmias (such as
premature atrial contractions, premature ventricular contractions,
Table 1
Baseline demographic information for the study participants, based on the two study protocols.
Symptom-driven
(n ¼ 192)
% Screening
(n ¼ 147)
% All participants
(n ¼ 339)
%
Age group (y)
<45 y 20 10.4 6 4.1 26 7.7
45e55 y 11 5.7 11 7.5 22 6.5
55e65 y 27 14.1 19 12.9 46 13.6
65e75 y 51 26.6 16 10.9 67 19.7
75 y 83 43.2 95 64.6 178 52.5
Mean age, y 70.6 ± 18.3 d 75.8 ± 17.2* d 72.9 ± 18 d
Sex, female, % 81 42.2 82 55.8* 163 48.10
Medical history, %
Hypertension, % 82 42.7 67 45.6 149 44
Diabetes, % 42 21.9 47 32* 89 26.3
Cardiovascular disease, % 51 26.6 61 41.5* 112 33
CHF, % 20 10.4 26 17.7 46 13.6
CKD, stage 3 7 3.7 10 6.8 17 5
* Indicates a value of p < 0.05 between the symptom-driven population and screening population.
CHF, congestive heart failure; CKD, chronic kidney disease.
Table 2
Difference in service months and total times of data transfer, based on the different
study protocols.
Symptom-driven protocol Screening protocol
Service months Times Service months Times
Age group (y)
<45 1.3 20.6 d 1
45e55 1.1 8.5 d 1
55e65 1.6 5.8 d 1
65e75 1 2.5 d 1
75 1.1 2.1 d 1
All participants 1.1 5.1 d 1
Handheld Remote Electrocardiography Recording Device 209and atrioventricular block or paroxysmal supraventricular tachy-
cardia showed a bimodal pattern in the symptom-driven popula-
tion. These associations remained unchanged after accounting for
sex differences, medical histories, and times of data transfer, which
may alter the incidence of AF (OR, 1.39 and 2.72; 95% CI, 1.04e1.87
and 1.46e5.04 for symptom-driven and screening protocols,Table 3
The prevalence of study participants identiﬁed with atrial ﬁbrillation (AF) or other cardi
different study protocols.
Symptom-driven
AF all* PAF* Others AF all*
Age group (y)
<45 0 0 8 0
45e55 1 2 2 0
55e65 7 3 1 1
65e75 2 1 4 0
75 16 8 15 29
All participants 26 14 30 30
* The trend is p < 0.05 across the different age groups.
PAF ¼ paroxysmal atrial ﬁbrillation.
Table 4
Univariate and multivariate models for age in predicting all atrial ﬁbrillation identiﬁcatio
Age, þ per decade AF all (all participants)
Odds ratio 95% CI Odds
Univariate model 1.72* 1.36 to 2.17 1.42*
Multivariate model
Model 1 1.73* 1.37 to 2.19 1.46*
Model 2 1.61* 1.25 to 2.06 1.39*
Model 3 1.39* 1.31 to 2.24 1.39*
*Indicates p < 0.05 in the models.
AF¼ atrial ﬁbrillation; CI¼ conﬁdence interval; Model 1, sex added; Model 2, sex, hyperte
sex, hypertension, diabetes, cardiovascular diseases, congestive heart failure, chronic kidrespectively; for both, p < 0.05). Study participants with identiﬁed
cardiac arrhythmias or AF were referred for adequate pharmaco-
logical management, whereas one patient (of two patients) with
atrioventricular block had cardiac pacemaker implantation.4. Discussion
Twelve-lead ECG is a proven robust tool for clinical utilization in
several scenarios, whereas wearable and wireless remote ECG de-
vices for easier andmore convenient clinical use has been emerging
as a clinical alternative method for identifying cardiac arrhythmias.
With advances in technology, the use of a single-channel ECG de-
vice as a new cardiac electrical signal transmission has recently
been widely used. Implantable continuous loop recorder in daily
clinical use may be an alternative, although the relatively invasive
procedure may limit its broad use and therefore it remains some-
what less attractive13,14.ac arrhythmias by using the electrocardiography device, based on age groups in the
Screening All
PAF Others* AF all* PAF Others
0 0 0 0 8
0 2 1 2 4
0 2 8 3 3
0 3 2 1 7
0 17 45 8 32
0 24 56 14 54
n by a handheld electrocardiography device.
AF all (symptom-driven) AF all (screening)
ratio 95% CI Odds ratio 95% CI
1.09 to 1.86 2.59* 1.54 to 4.35
1.11 to 1.91 2.56* 1.52 to 4.32
1.03 to 1.86 2.58* 1.43 to 4.63
1.04 to 1.87 2.72* 1.46 to 5.04
nsion, diabetes, cardiovascular diseases, and chronic kidney disease added; Model 3,
ney disease, and numbers of data transfer added.
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implantable cardiac devices or intracardiac leads capable of certain
diagnostic algorithms for arrhythmias have been feasible15,16 and
provides some advantages over continuous 24e48 hours Holter
monitoring17, whereas successful cardiac rhythm transfer and
simple preclinical diagnostic approach via handheld ECG tele-
monitoring are in progress18. In our current work, we had several
interesting ﬁndings. First, in our current work, we examined the
clinical feasibility of such a device in our center. By examining RR
regularity and wavelets patterns in current single strip device, we
were able to identify several key arrhythmia events in our study
participants. These patterns have been validated in clinical settings.
Therefore, we concluded in our study that a wearable ECG device
may be primarily clinically feasible in the identiﬁcation of rhythm
abnormalities, rather than for accurate parameters quantiﬁcation.
Second, we also demonstrated a wide range of data transfer
records among younger study participants in the symptom-driven
protocol with up to an average data transfer of 20 times among
younger individuals (i.e., <45 years), nearly nine data transfers in
middle-aged individuals (45e55 years), and less frequent utiliza-
tion of data recording in the elderly population (e.g., only 2 data
transfers during 1 month in individuals >65 years old). This infor-
mation indicated that younger participants, although similarly
symptom-driven, tended to use this device more frequently which
may differ from the elderly population. This may be in part because
of greater anxiety or relatively unstable autonomic nerve system19,
which may produce more clinical symptoms and unsteady elec-
trical activities.
Third, in accordance with previous ﬁndings, we observed a
relatively higher prevalence of AF among the elderly group, which
are among the most common cardiac arrhythmias in the advanced
age population20e22. This pattern did not change substantially
when factors such as sex, medical background, and times of data
transfer (i.e., frequency of use) were all taken into account. The
robust result from such age-related AF prevalence may provide
evidence for ECG device utilization in the elderly population in
daily practice. In addition, our data further support future targeted
study objects of the device in clinical practice, either for clinical
disease diagnosis or therapeutic intervention for disease preven-
tion (e.g., stroke).
Taken together, we demonstrated the feasibility of a handheld
ECG device implemented in daily outpatient clinics or in a
screening program via a remote health care system as a new and
novel service model. We also demonstrated the utilization differ-
ence and efﬁcacy of such device in different clinical settings and
identiﬁed various types of cardiac arrhythmias for subsequent
management. Advanced age was proven as an independent risk for
AF in both service models, regardless of medical backgrounds or
numbers of data transmission in our data; however, we suggest
that this new service model is clinically feasible and useful for
practical use in the health care system.
In our data, we demonstrated the feasibility of a handheld ECG
device implemented in daily outpatient clinics or in a screening
program via a remote health care system as a newand novel service
model. We also demonstrated the utilization difference and efﬁcacy
of such a device in different clinical service models and identiﬁed
various types of cardiac arrhythmias for subsequent management.
Advanced age was proven as an independent risk for AF in both
service models, regardless of medical backgrounds or numbers of
data transmission in our data; however, we suggest that this newservice model is clinically feasible and useful for practical use in the
health care system.References
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